Bradykinin B2 and dopamine D2 receptors form a functional dimer

Area of Science:

• Pharmacology
• Cell Biology
• Biochemistry

Background:

• G protein-coupled receptors (GPCRs) modulate cell functions via dimerization.
• Evidence suggests homodimerization and heterodimerization of receptors like bradykinin and dopamine receptors.
• Previous findings indicate interactions between angiotensin II receptors and B2R or D2R, hypothesizing B2R-D2R dimerization.

Purpose of the Study:

• To investigate the potential heterodimerization of bradykinin 2 receptor (B2R) and dopamine D2 receptor (D2R).
• To analyze the functional consequences of B2R-D2R heterodimerization on cellular signaling.

Main Methods:

• HEK293 cells were transfected with fluorescently tagged B2R and D2R.
• Confocal microscopy was used to assess receptor colocalization.
• Fluorescence-lifetime imaging microscopy-Förster resonance energy transfer (FLIM-FRET) confirmed heterodimerization.
• Intracellular calcium (Ca2+) and cyclic adenosine monophosphate (cAMP) levels were measured to analyze signaling pathways.

Main Results:

• Constitutive colocalization of B2R and D2R was observed in transfected HEK293 cells.
• Receptor colocalization was significantly enhanced by individual B2R or D2R agonists.
• FLIM-FRET confirmed B2R-D2R heterodimerization.
• Simultaneous agonist stimulation led to significant alterations in Ca2+ and cAMP signaling, indicating conformational changes upon dimerization.

Conclusions:

• Bradykinin 2 receptor (B2R) and dopamine D2 receptor (D2R) form constitutive heterodimers.
• B2R-D2R heterodimerization impacts their respective signaling pathways, affecting intracellular Ca2+ and cAMP levels.
• The findings suggest novel therapeutic strategies for modulating cellular functions through B2R-D2R interactions.